References
- Chan J KC, Jaffe E S, Ralfkiaer E R. Extranodal NK/T cell lymphoma, nasal type. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. Lyon, IARC 2001; 204–207
- Masucci M G. Epstein–Barr virus oncogenesis and the ubiquitin–proteasome system. Oncogene 2004; 23: 2107–2115
- Tang W G, Pavlish O A, Spiegelman V S, Parkhitko A A, Fuchs S Y. Interaction of Epstein–Barr virus latent membrane protein 1 with SCFHOS/βTrCP E3 ubiquitin ligase regulates extent of NF-κB Activation. J Biol Chem 2003; 278: 48942–48949
- Lim M S, Elenitoba-Johnson K SJ. Ubiquitin ligases in malignant lymphoma. Leuk Lymphoma 2004; 45: 1329–1339
- Stephen A G, Trausch-Azar J S, Ciechanover A, Schwartz A L. The ubiquitin-activating enzyme E1 is phosphorylated and localized to the nucleus in a cell cycle-dependent manner. J Biol Chem 1996; 271: 15608–15614
- Sillero M AG, Silles A DE. Sillero A. Synthesis of (di)nucleoside polyphosphates by the ubiquitin activating enzyme E1. FEBS Lett 2006; 579: 6223–6229
- Handley P M, Mueckler M, Siegel N R, Ciechanover A, Schwartz A L. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme El. PNAS 1991; 88: 258–262